Aging and Infections in Solid Organ Transplantation: Unchartered Territory.
作者信息
Abidi Maheen Z, Belga Sara, Limaye Ajit, McAdams-DeMarco Mara A
机构信息
Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, USA.
Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
出版信息
Transpl Infect Dis. 2025 Jan-Feb;27(1):e14431. doi: 10.1111/tid.14431. Epub 2024 Dec 28.
Abstract
摘要
相似文献
1
Aging and Infections in Solid Organ Transplantation: Unchartered Territory.
Transpl Infect Dis. 2025 Jan-Feb;27(1):e14431. doi: 10.1111/tid.14431. Epub 2024 Dec 28.
2
Association of Premature Immune Aging and Cytomegalovirus After Solid Organ Transplant.
Front Immunol. 2021 May 27;12:661551. doi: 10.3389/fimmu.2021.661551. eCollection 2021.
3
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
Transplant Rev (Orlando). 2014 Apr;28(2):84-91. doi: 10.1016/j.trre.2014.01.001. Epub 2014 Jan 27.
4
Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
Clin Transplant. 2019 Sep;33(9):e13512. doi: 10.1111/ctr.13512. Epub 2019 Mar 28.
5
Biomarkers of biological aging in recipients of solid organ transplantation and clinical outcomes: A scoping review.
Transpl Immunol. 2023 Aug;79:101851. doi: 10.1016/j.trim.2023.101851. Epub 2023 May 12.
6
Pre-transplant thymic function is associated with the risk of cytomegalovirus disease after solid organ transplantation.
Clin Microbiol Infect. 2015 May;21(5):511.e1-7. doi: 10.1016/j.cmi.2014.12.020. Epub 2015 Jan 14.
7
CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Clin Transplant. 2008 Jan-Feb;22(1):89-97. doi: 10.1111/j.1399-0012.2007.00750.x.
8
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Cochrane Database Syst Rev. 2024 May 3;5(5):CD003774. doi: 10.1002/14651858.CD003774.pub5.
9
Recurrent cytomegalovirus disease in solid-organ transplant recipients.
Transplant Proc. 1995 Oct;27(5 Suppl 1):34-7.
10
Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation.
J Clin Virol. 2012 Jun;54(2):125-9. doi: 10.1016/j.jcv.2012.02.020. Epub 2012 Mar 22.
本文引用的文献
1
Area-Level Social Deprivation and Cytomegalovirus Seropositivity at the Time of Solid Organ Transplant.
JAMA Netw Open. 2024 Oct 1;7(10):e2437878. doi: 10.1001/jamanetworkopen.2024.37878.
2
Patient years lost due to cytomegalovirus serostatus mismatching in the scientific registry of transplant recipients.
Front Immunol. 2024 Jan 9;14:1292648. doi: 10.3389/fimmu.2023.1292648. eCollection 2023.
3
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV.
J Acquir Immune Defic Syndr. 2024 Apr 15;95(5):470-478. doi: 10.1097/QAI.0000000000003377.
4
Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors.
J Heart Lung Transplant. 2024 Apr;43(4):615-625. doi: 10.1016/j.healun.2023.11.017. Epub 2023 Dec 6.
5
Development and Validation of an Abridged Physical Frailty Phenotype for Clinical Use: A Cohort Study Among Kidney Transplant Candidates.
J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1). doi: 10.1093/gerona/glad173.
6
Female sex and advanced age are associated with invasive cytomegalovirus disease in solid organ transplant recipients.
Transpl Infect Dis. 2022 Dec;24(6):e13960. doi: 10.1111/tid.13960. Epub 2022 Oct 19.
7
Immunosuppression Considerations for Older Kidney Transplant Recipients.
Curr Transplant Rep. 2021 Jun;8(2):100-110. doi: 10.1007/s40472-021-00321-6. Epub 2021 Apr 6.
8
Fostering healthy aging: The interdependency of infections, immunity and frailty.
Ageing Res Rev. 2021 Aug;69:101351. doi: 10.1016/j.arr.2021.101351. Epub 2021 May 7.
9
Frailty and aging-associated syndromes in lung transplant candidates and recipients.
Am J Transplant. 2021 Jun;21(6):2018-2024. doi: 10.1111/ajt.16439. Epub 2020 Dec 24.
10
Frailty Prevalence in Younger End-Stage Kidney Disease Patients Undergoing Dialysis and Transplantation.
Am J Nephrol. 2020;51(7):501-510. doi: 10.1159/000508576. Epub 2020 Jul 8.
Zotero 插件